CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2002; 52:23
doi: 10.3322/canjclin.52.1.23
© 2002 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Cancer Statistics, 2002
Right arrow An erratum has been published
Right arrow An erratum has been published
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M.

Cancer Statistics, 2002

Ahmedin Jemal, DVM, PhD, Andrea Thomas, MPH, Taylor Murray and Michael Thun, MD, MS

Dr. Jemal is Program Director for Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Thomas is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President for Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.

Every year the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival, using National Cancer Institute (NCI) incidence and National Center for Health Statistics (NCHS) mortality data. Incidence and death rates are age adjusted to the 1970 US standard population. It is estimated that 1,284,900 new cases of cancer will be diagnosed and 555,500 people will die from cancer in the United States in the year 2002. From 1992 to 1998, cancer death rates declined in males and females, while cancer incidence rates decreased among males and increased slightly among females. Most notably, African-American men showed the largest decline for both incidence and mortality. Nevertheless, African Americans still carry the highest burden of cancer with later-stage cancer diagnosis and poorer survival compared with whites. Despite the continued decline in cancer death rates, the total number of recorded cancer deaths in the United States continues to increase slightly due to the aging and expanding population.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
A. H. Calderwood, D. Huo, and D. T. Rubin
Association Between Colorectal Cancer and Urologic Cancers
Arch Intern Med, May 12, 2008; 168(9): 1003 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. V. Madhunapantula, D. Desai, A. Sharma, S. J. Huh, S. Amin, and G. P. Robertson
PBISe, a novel selenium-containing drug for the treatment of malignant melanoma
Mol. Cancer Ther., May 1, 2008; 7(5): 1297 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Baryshnikova, A. Destro, M. V. Infante, S. Cavuto, U. Cariboni, M. Alloisio, G. L. Ceresoli, R. Lutman, G. Brambilla, G. Chiesa, et al.
Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening Program
Clin. Cancer Res., March 15, 2008; 14(6): 1913 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Ronckers, M. M. Doody, J. E. Lonstein, M. Stovall, and C. E. Land
Multiple Diagnostic X-rays for Spine Deformities and Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 605 - 613.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. de la Luz Garcia-Hernandez, A. Gray, B. Hubby, O. J. Klinger, and W. M. Kast
Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Cancer Res., February 1, 2008; 68(3): 861 - 869.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H. Uemura, H. Ishiguro, Y. Ishiguro, K. Hoshino, S. Takahashi, and Y. Kubota
Angiotensin II Induces Oxidative Stress in Prostate Cancer
Mol. Cancer Res., February 1, 2008; 6(2): 250 - 258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. J. Dubinsky, C. Cuevas, M. K. Dighe, O. Kolokythas, and J. H. Hwang
High-Intensity Focused Ultrasound: Current Potential and Oncologic Applications
Am. J. Roentgenol., January 1, 2008; 190(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E.L. Crawford, T. Blomquist, D.N. Mullins, Y. Yoon, D.R. Hernandez, M. Al-Bagdhadi, J. Ruiz, J. Hammersley, and J.C. Willey
CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions
Carcinogenesis, December 1, 2007; 28(12): 2552 - 2559.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Mrkonjic, S. Raptis, R. C. Green, N. Monga, D. Daftary, E. Dicks, H.B. Younghusband, P. S. Parfrey, S. S. Gallinger, J. R. McLaughlin, et al.
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer
Carcinogenesis, December 1, 2007; 28(12): 2575 - 2580.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Matakidou, R. el Galta, E. L. Webb, M. F. Rudd, H. Bridle, the GELCAPS Consortium, T. Eisen, and R. S. Houlston
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer
Hum. Mol. Genet., October 1, 2007; 16(19): 2333 - 2340.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Veronesi, M. Bellomi, U. Veronesi, G. Paganelli, P. Maisonneuve, P. Scanagatta, F. Leo, G. Pelosi, L. Travaini, C. Rampinelli, et al.
Role of Positron Emission Tomography Scanning in the Management of Lung Nodules Detected at Baseline Computed Tomography Screening
Ann. Thorac. Surg., September 1, 2007; 84(3): 959 - 966.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. A. Zagorski, E. S. Knudsen, and M. F. Reed
Retinoblastoma Deficiency Increases Chemosensitivity in Lung Cancer
Cancer Res., September 1, 2007; 67(17): 8264 - 8273.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. Wang, Z. Wang, W. Yao, H. Xie, J. Xu, and L. Tian
Role of 99mTc-Octreotide Acetate Scintigraphy in Suspected Lung Cancer Compared with 18F-FDG Dual-Head Coincidence Imaging
J. Nucl. Med., September 1, 2007; 48(9): 1442 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S. Sharma and S. J D O'Keefe
Environmental influences on the high mortality from colorectal cancer in African Americans
Postgrad. Med. J., September 1, 2007; 83(983): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T.-M. Hong, Y.-L. Chen, Y.-Y. Wu, A. Yuan, Y.-C. Chao, Y.-C. Chung, M.-H. Wu, S.-C. Yang, S.-H. Pan, J.-Y. Shih, et al.
Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer
Clin. Cancer Res., August 15, 2007; 13(16): 4759 - 4768.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Basu, G. Cordovano, I. Das, T. J. Belbin, C. Guha, and V. L. Schramm
A Transition State Analogue of 5'-Methylthioadenosine Phosphorylase Induces Apoptosis in Head and Neck Cancers
J. Biol. Chem., July 20, 2007; 282(29): 21477 - 21486.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. Alencar, M. A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder, and U. Mahmood
Colonic Adenocarcinomas: Near-Infrared Microcatheter Imaging of Smart Probes for Early Detection--Study in Mice
Radiology, July 1, 2007; 244(1): 232 - 238.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. Zhao, A. C. Chang, C. Li, K. A. Shedden, D. G. Thomas, D. E. Misek, A. P. Manoharan, T. J. Giordano, D. G. Beer, and D. M. Lubman
Comparative Proteomics Analysis of Barrett Metaplasia and Esophageal Adenocarcinoma Using Two-dimensional Liquid Mass Mapping
Mol. Cell. Proteomics, June 1, 2007; 6(6): 987 - 999.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. J. Ford, L. Shen, Y. C. Lin-Lee, L. V. Pham, A. Multani, H.-J. Zhou, A. T. Tamayo, C. Zhang, L. Hawthorn, J. K. Cowell, et al.
Development of a murine model for blastoid variant mantle-cell lymphoma
Blood, June 1, 2007; 109(11): 4899 - 4906.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
D. Sariya, K. Ruth, R. Adams-McDonnell, C. Cusack, X. Xu, R. Elenitsas, J. Seykora, T. Pasha, P. Zhang, M. Baldassano, et al.
Clinicopathologic Correlation of Cutaneous Metastases: Experience From a Cancer Center
Arch Dermatol, May 1, 2007; 143(5): 613 - 620.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. R. Hussain, N. A. Al-Jomah, A. K. Siraj, P. Manogaran, K. Al-Hussein, J. Abubaker, L. C. Platanias, K. S. Al-Kuraya, and S. Uddin
Sanguinarine-Dependent Induction of Apoptosis in Primary Effusion Lymphoma Cells
Cancer Res., April 15, 2007; 67(8): 3888 - 3897.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. J. Quann, F. Khwaja, K. H. Zavitz, and D. Djakiew
The Aryl Propionic Acid R-Flurbiprofen Selectively Induces p75NTR-Dependent Decreased Survival of Prostate Tumor Cells
Cancer Res., April 1, 2007; 67(7): 3254 - 3262.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T.-J. Liu, T. LaFortune, T. Honda, O. Ohmori, S. Hatakeyama, T. Meyer, D. Jackson, J. de Groot, and W.K. A. Yung
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
Mol. Cancer Ther., April 1, 2007; 6(4): 1357 - 1367.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. Raptis, M. Mrkonjic, R. C. Green, V. V. Pethe, N. Monga, Y. M. Chan, D. Daftary, E. Dicks, B. H. Younghusband, P. S. Parfrey, et al.
MLH1 -93G>A Promoter Polymorphism and the Risk of Microsatellite-Unstable Colorectal Cancer
J Natl Cancer Inst, March 21, 2007; 99(6): 463 - 474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Giangreco, K. R. Groot, and S. M. Janes
Lung Cancer and Lung Stem Cells: Strange Bedfellows?
Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
U.S. Preventive Services Task Force*
Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med, March 6, 2007; 146(5): 361 - 364.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. C.K. Leung and J.-H. Choi
Endocrine signaling in ovarian surface epithelium and cancer
Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
C. Gebitekin, A. S Bayram, B. Tunca, and S. A Balaban
Clinical Significance of p53 Gene Mutation in T1-2N0 Non-Small Cell Lung Cancer
Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): 35 - 38.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. d. l. L. Garcia-Hernandez, A. Gray, B. Hubby, and W. M. Kast
In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer
Cancer Res., February 1, 2007; 67(3): 1344 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
T Andre, C Tournigand, L Mineur, R Fellague-Chebra, M Flesch, M Mabro, M Hebbar, S Postel Vinay, F. Bidard, C Louvet, et al.
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study
Ann. Onc., January 1, 2007; 18(1): 77 - 81.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Schwaninger, C. A. Rentsch, A. Wetterwald, G. van der Horst, R. L. van Bezooijen, G. van der Pluijm, C. W.G.M. Lowik, K. Ackermann, W. Pyerin, F. C. Hamdy, et al.
Lack of Noggin Expression by Cancer Cells Is a Determinant of the Osteoblast Response in Bone Metastases
Am. J. Pathol., January 1, 2007; 170(1): 160 - 175.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Kuehl, P. Veit, S. J. Rosenbaum, A. Bockisch, and G. Antoch
Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT Protocols for Imaging Cancers of the Chest and Abdomen
J. Nucl. Med., January 1, 2007; 48(1_suppl): 45S - 57S.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
N. J. D'Silva, D.-J. Summerlin, K. G. Cordell, R. A. Abdelsayed, C. E. Tomich, C. T. Hanks, D. Fear, and S. Meyrowitz
Metastatic tumors in the jaws: A retrospective study of 114 cases
J Am Dent Assoc, December 1, 2006; 137(12): 1667 - 1672.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Lee, M.-K. Choi, Y.-J. Lee, J.-L. Ku, K.-H. Kim, J.-S. Choi, and S.-J. Lim
Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells
Carcinogenesis, November 1, 2006; 27(11): 2308 - 2315.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-Z. Qin, H. Xin, L. A. Sitailo, M. F. Denning, and B. J. Nickoloff
Enhanced Killing of Melanoma Cells by Simultaneously Targeting Mcl-1 and NOXA
Cancer Res., October 1, 2006; 66(19): 9636 - 9645.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Gao, D. L. Dai, M. Martinka, and G. Li
Prognostic Significance of Nuclear Factor-{kappa}B p105/p50 in Human Melanoma and Its Role in Cell Migration.
Cancer Res., September 1, 2006; 66(17): 8382 - 8388.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Khanbolooki, S. T. Nawrocki, T. Arumugam, R. Andtbacka, M. S. Pino, R. Kurzrock, C. D. Logsdon, J. L. Abbruzzese, and D. J. McConkey
Nuclear factor-{kappa}B maintains TRAIL resistance in human pancreatic cancer cells.
Mol. Cancer Ther., September 1, 2006; 5(9): 2251 - 2260.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-w. Wang, Y. Qu, J.-f. Li, X.-h. Chen, B.-y. Liu, Q.-l. Gu, and Z.-g. Zhu
In vitro and In vivo Evidence of Metallopanstimulin-1 in Gastric Cancer Progression and Tumorigenicity.
Clin. Cancer Res., August 15, 2006; 12(16): 4965 - 4973.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. M. Kokkinakis, A. G. Brickner, J. M. Kirkwood, X. Liu, J. E. Goldwasser, A. Kastrama, C. Sander, D. Bocangel, and S. Chada
Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress
Mol. Cancer Res., August 1, 2006; 4(8): 575 - 589.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. M. Goldberg, D. J. Sargent, R. F. Morton, C. S. Fuchs, R. K. Ramanathan, S. K. Williamson, B. P. Findlay, H. C. Pitot, and S. Alberts
Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial
J. Clin. Oncol., July 20, 2006; 24(21): 3347 - 3353.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M.-F. Tsai, C.-C. Wang, G.-C. Chang, C.-Y. Chen, H.-Y. Chen, C.-L. Cheng, Y.-P. Yang, C.-Y. Wu, F.-Y. Shih, C.-C. Liu, et al.
A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
J Natl Cancer Inst, June 21, 2006; 98(12): 825 - 838.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Tanaka, J. Huang, S. Hirai, M. Kuroki, M. Kuroki, N. Watanabe, K. Tomihara, K. Kato, and H. Hamada
Carcinoembryonic Antigen-Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus Vectors.
Clin. Cancer Res., June 15, 2006; 12(12): 3803 - 3813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. K. Misra, R. Deedwania, and S. V. Pizzo
Activation and Cross-talk between Akt, NF-{kappa}B, and Unfolded Protein Response Signaling in 1-LN Prostate Cancer Cells Consequent to Ligation of Cell Surface-associated GRP78
J. Biol. Chem., May 12, 2006; 281(19): 13694 - 13707.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Aikawa, J. Gunn, S. M. Spong, S. J. Klaus, and M. Korc
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer
Mol. Cancer Ther., May 1, 2006; 5(5): 1108 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Kosugi, A. Miyajima, E. Kikuchi, Y. Horiguchi, and M. Murai
Angiotensin II Type 1 Receptor Antagonist Candesartan as an Angiogenic Inhibitor in a Xenograft Model of Bladder Cancer.
Clin. Cancer Res., May 1, 2006; 12(9): 2888 - 2893.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. R. Vuillemenot, J. A. Hutt, and S. A. Belinsky
Gene Promoter Hypermethylation in Mouse Lung Tumors
Mol. Cancer Res., April 1, 2006; 4(4): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Belinsky, K. C. Liechty, F. D. Gentry, H. J. Wolf, J. Rogers, K. Vu, J. Haney, T. C. Kennedy, F. R. Hirsch, Y. Miller, et al.
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
Cancer Res., March 15, 2006; 66(6): 3338 - 3344.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Caldas, F. O. Jaynes, M. W. Boyer, S. Hammond, and R. A. Altura
Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy.
Mol. Cancer Ther., March 1, 2006; 5(3): 693 - 703.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W.-W. Jiang, E. Rosenbaum, E. Mambo, M. Zahurak, B. Masayesva, A. L. Carvalho, S. Zhou, W. H. Westra, A. J. Alberg, D. Sidransky, et al.
Decreased Mitochondrial DNA Content in Posttreatment Salivary Rinses from Head and Neck Cancer Patients
Clin. Cancer Res., March 1, 2006; 12(5): 1564 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Brandacher, A. Perathoner, R. Ladurner, S. Schneeberger, P. Obrist, C. Winkler, E. R. Werner, G. Werner-Felmayer, H. G. Weiss, G. Gobel, et al.
Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells
Clin. Cancer Res., February 15, 2006; 12(4): 1144 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. S. Schleypen, N. Baur, R. Kammerer, P. J. Nelson, K. Rohrmann, E. F. Grone, M. Hohenfellner, A. Haferkamp, H. Pohla, D. J. Schendel, et al.
Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma
Clin. Cancer Res., February 1, 2006; 12(3): 718 - 725.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. R. McWhirter, A. Kretz-Rommel, A. Saven, T. Maruyama, K. N. Potter, C. I. Mockridge, E. P. Ravey, F. Qin, and K. S. Bowdish
Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation
PNAS, January 24, 2006; 103(4): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Tournigand, A. Cervantes, A. Figer, G. Lledo, M. Flesch, M. Buyse, L. Mineur, E. Carola, P.-L. Etienne, F. Rivera, et al.
OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer--A GERCOR Study
J. Clin. Oncol., January 20, 2006; 24(3): 394 - 400.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P Veit, C Kuhle, T Beyer, H Kuehl, C U Herborn, G Borsch, H Stergar, J Barkhausen, A Bockisch, and G Antoch
Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer
Gut, January 1, 2006; 55(1): 68 - 73.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. A. Magee, L.-w. Chang, G. D. Stormo, and J. Milbrandt
Direct, Androgen Receptor-Mediated Regulation of the FKBP5 Gene via a Distal Enhancer Element
Endocrinology, January 1, 2006; 147(1): 590 - 598.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Wei, M. Kanai, S. Huang, and K. Xie
Emerging role of KLF4 in human gastrointestinal cancer
Carcinogenesis, January 1, 2006; 27(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Tauro, C. Craddock, K. Peggs, G. Begum, P. Mahendra, G. Cook, J. Marsh, D. Milligan, A. Goldstone, A. Hunter, et al.
Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
J. Clin. Oncol., December 20, 2005; 23(36): 9387 - 9393.
[Abstract] [Full Text] [PDF]